Skip to main content
Improve Medical Instruments CO., Ltd. logo

Improve Medical Instruments CO., Ltd. — Investor Relations & Filings

Ticker · 300030 ISIN · CNE100000JL3 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 1,954 across all filing types
Latest filing 2024-08-14 Report Publication Anno…
Country CN China
Listing Shenzhen Stock Exchange 300030

About Improve Medical Instruments CO., Ltd.

https://www.improve-medical.com

Improve Medical Instruments CO., Ltd. focuses on the development, production, and distribution of clinical laboratory and nursing solutions. The core product range includes evacuated blood collection systems, specimen collection and transport media, and laboratory automation equipment. The company also provides medical imaging components and point-of-care testing (POCT) systems. By integrating research and development with advanced manufacturing, the organization supports clinical diagnostics and patient care through high-precision tools designed for healthcare facilities and research laboratories. Its offerings are characterized by a commitment to diagnostic safety and efficiency across global markets.

Recent filings

Filing Released Lang Actions
关于披露2024年半年度报告及摘要的提示性公告
Report Publication Announcement Classification · 100% confidence The document is a short announcement (424 characters) indicating that the company has approved its 2024 half-year report and summary, and that these reports will be disclosed on a specified website on August 15, 2024. It does not contain the actual half-year financial report or substantive financial data, but rather informs investors about the upcoming publication of the report. According to the 'MENU VS MEAL' rule, such a brief notice about the report's release is classified as a Report Publication Announcement (RPA), not as the Interim/Quarterly Report (IR) itself.
2024-08-14 Chinese
监事会决议公告
Regulatory Filings Classification · 95% confidence The document is a resolution announcement from the Supervisory Board of Yangpu Medical Technology Co., Ltd. regarding the approval of the company's 2024 semi-annual report and its summary. It states that the Supervisory Board has reviewed and approved the report, confirming its accuracy and completeness. The document references the actual semi-annual report (2024 half-year report) and its summary but does not contain the financial data or the report itself. Instead, it announces the approval and provides links to the full report elsewhere. The document length is short (709 characters), and it is an announcement of the approval of a report rather than the report itself. Therefore, it fits best under Regulatory Filings (RNS) as a general regulatory announcement related to the report approval, not the Interim/Quarterly Report (IR) itself.
2024-08-14 Chinese
董事会决议公告
Board/Management Information Classification · 95% confidence The document is a board meeting resolution announcement from 阳普医疗科技股份有限公司 regarding the approval of the company's 2024 half-year report and its summary. It mentions the board's review and approval of the 2024 half-year report but does not contain the report itself. The document is short (800 characters) and serves as an official announcement of the board's decision rather than the full interim report. According to the 'Menu vs Meal' rule, this is an announcement related to a report, not the report itself. Therefore, the appropriate classification is 'Board/Management Information' (MANG) because it is a board meeting resolution announcement about the report approval, not the report itself or a regulatory filing about the report publication.
2024-08-14 Chinese
2024年半年度报告
Interim / Quarterly Report Classification · 100% confidence The document is titled "阳普医疗科技股份有限公司2024 年半年度报告全文" which translates to "Improve Medical Instruments Co., Ltd. 2024 Semi-Annual Report Full Text." It explicitly states it is a half-year report covering the period from January 1, 2024 to June 30, 2024. The content includes detailed financial data, management discussion and analysis, company overview, business segments, and other comprehensive information typical of an interim or quarterly report. The document length is about 15,000 characters, indicating it is a full report rather than a brief announcement or summary. There is no indication that this is an announcement of a report publication or a certification letter. Therefore, this document fits the definition of an Interim / Quarterly Report (IR). H1 2024
2024-08-14 Chinese
2024年半年度报告摘要
Interim / Quarterly Report Classification · 95% confidence The document is titled as a '2024 半年度报告摘要' which translates to '2024 Semi-Annual Report Summary'. It contains detailed financial data such as revenue, net profit, cash flow, earnings per share, and asset information for the half-year period. It also includes shareholder information and notes on board attendance. The document length is 2729 characters, which is relatively short but it contains substantive financial data and analysis, not just an announcement or a link to a full report. The content matches the characteristics of an Interim / Quarterly Report (IR) as it covers a period shorter than a full fiscal year with actual financial statements and analysis. Therefore, the correct classification is IR (Interim / Quarterly Report). H1 2024
2024-08-14 Chinese
关于全资子公司医疗器械产品完成延续注册的公告
Regulatory Filings Classification · 95% confidence The document is an announcement from a company about its wholly-owned subsidiary receiving renewed registration certificates for medical device products from the National Medical Products Administration. It details the product names, registration numbers, classifications, and validity periods. The document also discusses the impact and risk related to these registrations. There is no financial data, no mention of a report being attached or published, and no indication of a meeting or voting results. This is a regulatory announcement about product registration status, which does not fit into financial reports or management changes. Therefore, it best fits the category of Regulatory Filings (RNS), which is the fallback for miscellaneous regulatory announcements that do not fit other categories.
2024-08-06 Chinese

Browse filings by year

18 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.